Cargando…

Loss of CPAP causes sustained EGFR signaling and epithelial-mesenchymal transition in oral cancer

Higher epidermal growth factor receptor (EGFR) signaling can contribute to tumor metastasis and resistance to therapies in oral squamous cell carcinoma (OSCC). EGFR signaling can promote epithelial-mesenchymal transition (EMT) in OSCC. EMT is a process by which epithelial cells acquire invasive prop...

Descripción completa

Detalles Bibliográficos
Autores principales:	Gudi, Radhika R., Janakiraman, Harinarayanan, Howe, Philip H., Palanisamy, Viswanathan, Vasu, Chenthamarakshan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Impact Journals LLC 2021
Materias:	Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8057274/ https://www.ncbi.nlm.nih.gov/pubmed/33889303 http://dx.doi.org/10.18632/oncotarget.27932

Ejemplares similares

Centrosomal P4.1-associated protein (CPAP) positively regulates endocytic vesicular transport and lysosome targeting of EGFR
por: Gudi, Radhika, et al.
Publicado: (2021)

Dynamics of Structural and Functional Changes in Gut Microbiota during Treatment with a Microalgal β-Glucan, Paramylon and the Impact on Gut Inflammation
por: Taylor, Harrison B., et al.
Publicado: (2020)

Abundance and nuclear antigen reactivity of intestinal and fecal Immunoglobulin A in lupus-prone mice at younger ages correlate with the onset of eventual systemic autoimmunity
por: Sun, Wei, et al.
Publicado: (2020)

Combination of Autophagy Selective Therapeutics With Doxil: An Assessment of Pathological Toxicity
por: Helke, Kristi L., et al.
Publicado: (2022)

Engineered Dendritic Cell-Directed Concurrent Activation of Multiple T cell Inhibitory Pathways Induces Robust Immune Tolerance
por: Gudi, Radhika R., et al.
Publicado: (2019)

Repression of caspase-3 and RNA-binding protein HuR cleavage by cyclooxygenase-2 promotes drug resistance in oral squamous cell carcinoma
por: Janakiraman, Harinarayanan, et al.
Publicado: (2016)

pH of Drinking Water Influences the Composition of Gut Microbiome and Type 1 Diabetes Incidence
por: Sofi, M. Hanief, et al.
Publicado: (2014)

TLR2- and Dectin 1–Associated Innate Immune Response Modulates T-Cell Response to Pancreatic β-Cell Antigen and Prevents Type 1 Diabetes
por: Karumuthil-Melethil, Subha, et al.
Publicado: (2015)

hnRNP E1 at the crossroads of translational regulation of epithelial-mesenchymal transition
por: Grelet, Simon, et al.
Publicado: (2019)

Hypoxia Activated EGFR Signaling Induces Epithelial to Mesenchymal Transition (EMT)
por: Misra, Ashish, et al.
Publicado: (2012)

Impact of Prebiotic β-glucan Treatment at Juvenile Age on the Gut Microbiota Composition and the Eventual Type 1 Diabetes Onset in Non-obese Diabetic Mice
por: Taylor, Harrison B., et al.
Publicado: (2021)

Mesenchymal-Epithelial Transition in Oral Cancer
por: Patil, Shankargouda, et al.
Publicado: (2015)

Epithelial-mesenchymal transition is associated with osteopontin-induced EGFR‑TKI resistance in EGFR mutant non-small cell lung cancer
por: Chen, Junjie, et al.
Publicado: (2023)

Notch signaling: targeting cancer stem cells and epithelial-to-mesenchymal transition
por: Espinoza, Ingrid, et al.
Publicado: (2013)

TWIST1 a New Determinant of Epithelial to Mesenchymal Transition in EGFR Mutated Lung Adenocarcinoma
por: Pallier, Karine, et al.
Publicado: (2012)

RYBP Inhibits Progression and Metastasis of Lung Cancer by Suppressing EGFR Signaling and Epithelial-Mesenchymal Transition()()
por: Dinglin, Xiaoxiao, et al.
Publicado: (2017)

Prognostic Outcome of Mesenchymal Transition Biomarkers in Correlation with EGFR Expression in Epithelial Ovarian Carcinoma Patients
por: Kamal, Israa Mostafa, et al.
Publicado: (2022)

SET contributes to the epithelial-mesenchymal transition of pancreatic cancer
por: Mody, Hardik R., et al.
Publicado: (2017)

Loss of ATM accelerates pancreatic cancer formation and epithelial–mesenchymal transition
por: Russell, Ronan, et al.
Publicado: (2015)

A case of EGFR mutant lung adenocarcinoma that acquired resistance to EGFR-tyrosine kinase inhibitors with MET amplification and epithelial-to-mesenchymal transition
por: Miyoshi, Seigo, et al.
Publicado: (2015)

Pleiotropic Roles of Non-Coding RNAs in TGF-β-Mediated Epithelial-Mesenchymal Transition and Their Functions in Tumor Progression
por: Grelet, Simon, et al.
Publicado: (2017)

ERβ1 represses basal-like breast cancer epithelial to mesenchymal transition by destabilizing EGFR
por: Thomas, Christoforos, et al.
Publicado: (2012)

MicroRNA-147 Induces a Mesenchymal-To-Epithelial Transition (MET) and Reverses EGFR Inhibitor Resistance
por: Lee, Chang Gong, et al.
Publicado: (2014)

Osteoglycin (OGN) reverses epithelial to mesenchymal transition and invasiveness in colorectal cancer via EGFR/Akt pathway
por: Hu, Xiang, et al.
Publicado: (2018)

Cadmium Activates EGFR/STAT5 Signaling to Overcome Calcium Chelation and Promote Epithelial to Mesenchymal Transition
por: Stavrou, Aikaterini, et al.
Publicado: (2023)

Smoking-induced control of miR-133a-3p alters the expression of EGFR and HuR in HPV-infected oropharyngeal cancer
por: House, Reniqua, et al.
Publicado: (2018)

Loss of CLCA4 Promotes Epithelial-to-Mesenchymal Transition in Breast Cancer Cells
por: Yu, Yang, et al.
Publicado: (2013)

Epithelial-Mesenchymal Transition in Oral Squamous Cell Carcinoma
por: Krisanaprakornkit, Suttichai, et al.
Publicado: (2012)

Critical evaluation of an autologous peripheral blood mononuclear cell-based humanized cancer model
por: Janakiraman, Harinarayanan, et al.
Publicado: (2022)

The Epithelial-to-Mesenchymal Transition in Cancer
por: Roche, Joëlle
Publicado: (2018)

Epithelial–mesenchymal transition in cancer
por: Moustakas, Aristidis, et al.
Publicado: (2017)

Cortactin in Epithelial–Mesenchymal Transition
por: Ji, Rong, et al.
Publicado: (2020)

Glycobiology of the Epithelial to Mesenchymal Transition
por: Pucci, Michela, et al.
Publicado: (2021)

Epithelial–Mesenchymal Transition (EMT)
por: Manfioletti, Guidalberto, et al.
Publicado: (2023)

Grape Seed Proanthocyanidins Inhibit the Invasiveness of Human HNSCC Cells by Targeting EGFR and Reversing the Epithelial-To-Mesenchymal Transition
por: Sun, Qian, et al.
Publicado: (2012)

Phytosphingosine exhibits an anti-epithelial–mesenchymal transition function by the inhibition of EGFR signaling in human breast cancer cells
por: Kang, Hye-Min, et al.
Publicado: (2017)

PRMT5 promotes epithelial‐mesenchymal transition via EGFR‐β‐catenin axis in pancreatic cancer cells
por: Ge, Lu, et al.
Publicado: (2019)

DCLK1 Drives EGFR-TKI-Acquired Resistance in Lung Adenocarcinoma by Remodeling the Epithelial–Mesenchymal Transition Status
por: Yan, Rui, et al.
Publicado: (2023)

[Formula: see text] -test: robust distance-based multivariate analysis of variance
por: Hamidi, Bashir, et al.
Publicado: (2019)

Post-transcriptional regulatory network of epithelial-to-mesenchymal and mesenchymal-to-epithelial transitions
por: Guo, Fei, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_c7agvv0vfmjva49qluh3jsfbb7